905 related articles for article (PubMed ID: 22536790)
1. In vivo biodistribution of prion- and GM1-targeted polymersomes following intravenous administration in mice.
Stojanov K; Georgieva JV; Brinkhuis RP; van Hest JC; Rutjes FP; Dierckx RA; de Vries EF; Zuhorn IS
Mol Pharm; 2012 Jun; 9(6):1620-7. PubMed ID: 22536790
[TBL] [Abstract][Full Text] [Related]
2. A filter-free blood-brain barrier model to quantitatively study transendothelial delivery of nanoparticles by fluorescence spectroscopy.
De Jong E; Williams DS; Abdelmohsen LKEA; Van Hest JCM; Zuhorn IS
J Control Release; 2018 Nov; 289():14-22. PubMed ID: 30243824
[TBL] [Abstract][Full Text] [Related]
3. Brain iron homeostasis.
Moos T
Dan Med Bull; 2002 Nov; 49(4):279-301. PubMed ID: 12553165
[TBL] [Abstract][Full Text] [Related]
4. Polymersomes conjugated with des-octanoyl ghrelin for the delivery of therapeutic and imaging agents into brain tissues.
Chen YC; Chiang CF; Chen LF; Liao SC; Hsieh WY; Lin WL
Biomaterials; 2014 Feb; 35(6):2051-65. PubMed ID: 24315575
[TBL] [Abstract][Full Text] [Related]
5. Integrated platform for brain imaging and drug delivery across the blood-brain barrier.
Iqbal U; Abulrob A; Stanimirovic DB
Methods Mol Biol; 2011; 686():465-81. PubMed ID: 21082388
[TBL] [Abstract][Full Text] [Related]
6. LDLR-mediated peptide-22-conjugated nanoparticles for dual-targeting therapy of brain glioma.
Zhang B; Sun X; Mei H; Wang Y; Liao Z; Chen J; Zhang Q; Hu Y; Pang Z; Jiang X
Biomaterials; 2013 Dec; 34(36):9171-82. PubMed ID: 24008043
[TBL] [Abstract][Full Text] [Related]
7. Targeting rat anti-mouse transferrin receptor monoclonal antibodies through blood-brain barrier in mouse.
Lee HJ; Engelhardt B; Lesley J; Bickel U; Pardridge WM
J Pharmacol Exp Ther; 2000 Mar; 292(3):1048-52. PubMed ID: 10688622
[TBL] [Abstract][Full Text] [Related]
8. Active targeting of brain tumors using nanocarriers.
Béduneau A; Saulnier P; Benoit JP
Biomaterials; 2007 Nov; 28(33):4947-67. PubMed ID: 17716726
[TBL] [Abstract][Full Text] [Related]
9. Angiopep-2 modified PE-PEG based polymeric micelles for amphotericin B delivery targeted to the brain.
Shao K; Huang R; Li J; Han L; Ye L; Lou J; Jiang C
J Control Release; 2010 Oct; 147(1):118-26. PubMed ID: 20609375
[TBL] [Abstract][Full Text] [Related]
10. Dual-targeting topotecan liposomes modified with tamoxifen and wheat germ agglutinin significantly improve drug transport across the blood-brain barrier and survival of brain tumor-bearing animals.
Du J; Lu WL; Ying X; Liu Y; Du P; Tian W; Men Y; Guo J; Zhang Y; Li RJ; Zhou J; Lou JN; Wang JC; Zhang X; Zhang Q
Mol Pharm; 2009; 6(3):905-17. PubMed ID: 19344115
[TBL] [Abstract][Full Text] [Related]
11. Gene delivery targeted to the brain using an Angiopep-conjugated polyethyleneglycol-modified polyamidoamine dendrimer.
Ke W; Shao K; Huang R; Han L; Liu Y; Li J; Kuang Y; Ye L; Lou J; Jiang C
Biomaterials; 2009 Dec; 30(36):6976-85. PubMed ID: 19765819
[TBL] [Abstract][Full Text] [Related]
12. Polymersomes conjugated with des-octanoyl ghrelin and folate as a BBB-penetrating cancer cell-targeting delivery system.
Chen YC; Chiang CF; Chen LF; Liang PC; Hsieh WY; Lin WL
Biomaterials; 2014 Apr; 35(13):4066-81. PubMed ID: 24513319
[TBL] [Abstract][Full Text] [Related]
13. Brain targeting of nerve growth factor using poly(butyl cyanoacrylate) nanoparticles.
Kurakhmaeva KB; Djindjikhashvili IA; Petrov VE; Balabanyan VU; Voronina TA; Trofimov SS; Kreuter J; Gelperina S; Begley D; Alyautdin RN
J Drug Target; 2009 Sep; 17(8):564-74. PubMed ID: 19694610
[TBL] [Abstract][Full Text] [Related]
14. Polymersomes conjugated to 83-14 monoclonal antibodies: in vitro targeting of brain capillary endothelial cells.
Dieu LH; Wu D; Palivan CG; Balasubramanian V; Huwyler J
Eur J Pharm Biopharm; 2014 Oct; 88(2):316-24. PubMed ID: 24929212
[TBL] [Abstract][Full Text] [Related]
15. Liposome formulated with TAT-modified cholesterol for enhancing the brain delivery.
Qin Y; Chen H; Yuan W; Kuai R; Zhang Q; Xie F; Zhang L; Zhang Z; Liu J; He Q
Int J Pharm; 2011 Oct; 419(1-2):85-95. PubMed ID: 21807083
[TBL] [Abstract][Full Text] [Related]
16. Comparison of four different peptides to enhance accumulation of liposomes into the brain.
Qin Y; Zhang Q; Chen H; Yuan W; Kuai R; Xie F; Zhang L; Wang X; Zhang Z; Liu J; He Q
J Drug Target; 2012 Apr; 20(3):235-45. PubMed ID: 22188312
[TBL] [Abstract][Full Text] [Related]
17. Delivery of beta-galactosidase to mouse brain via the blood-brain barrier transferrin receptor.
Zhang Y; Pardridge WM
J Pharmacol Exp Ther; 2005 Jun; 313(3):1075-81. PubMed ID: 15718287
[TBL] [Abstract][Full Text] [Related]
18. Drug targeting to the brain using avidin-biotin technology in the mouse; (blood-brain barrier, monoclonal antibody, transferrin receptor, Alzheimer's disease).
Jeong Lee H; Pardridge WM
J Drug Target; 2000; 8(6):413-24. PubMed ID: 11328667
[TBL] [Abstract][Full Text] [Related]
19. Nano-enabled delivery systems across the blood-brain barrier.
Hwang SR; Kim K
Arch Pharm Res; 2014 Jan; 37(1):24-30. PubMed ID: 24170511
[TBL] [Abstract][Full Text] [Related]
20. Nanostructure-based drug delivery systems for brain targeting.
Haque S; Md S; Alam MI; Sahni JK; Ali J; Baboota S
Drug Dev Ind Pharm; 2012 Apr; 38(4):387-411. PubMed ID: 21954902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
